📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Prospective direct comparison of biologic treatments for severe eosinophilic asthma: Findings from the PRISM study. (2024)

First Author: Pham DD

Attributed to: MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.anai.2023.11.005

PubMed Identifier: 37977324

Publication URI: http://europepmc.org/abstract/MED/37977324

Type: Journal Article/Review

Volume: 132

Parent Publication: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Issue: 4

ISSN: 1081-1206